Janssen Vaccines & Prevention B.v.

This study tested a new universal flu vaccine (INFLUENZA G1 mHA) in 170 healthy adults aged 18-45. The goal was to see if it is safe and triggers an immune response against a part of the flu virus that doesn't change much between strains. If it works, it could protect against man…

This study tested an experimental vaccine to prevent serious lung infections caused by RSV in adults aged 60 and older. Over 25,000 participants received either the vaccine or a placebo. The goal was to see if the vaccine could reduce cases of RSV-related lower respiratory tract …